Nurix Therapeutics Inc Cash Flow Quality Index

Latest as of May 2020: -1.90x

Nurix Therapeutics Inc cash flow quality index. Nurix Therapeutics Inc (NRIX) has a Cash Flow Quality Index of -1.90x as of May 2020. Operating cash flow of $-14.43 Million is below net income of $7.58 Million, suggesting accrual-heavy earnings not yet converted to cash. See Nurix Therapeutics Inc (NRIX) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.90x
Operating CF / Net Income

Operating Cash Flow

$-14.43 Million
USD

Net Income

$7.58 Million
USD

Data as of

May 2020
Most recent filing

Nurix Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Nurix Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Nurix Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Nurix Therapeutics Inc generate cash.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.